Source: PRcom

Press Release: CPSI Biotech : US Patent Issued on CPSI's FrostBite Pancreas Cancer Cryoablation Catheter

Latest patent covers an endoscopic-based cryocatheter (FrostBite ) designed to provide an advanced approach for targeting pancreatic and other gastroenterological based cancers. [PR.com]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
John M. Baust's photo - President & CEO of CPSI Biotech

President & CEO

John M. Baust

CEO Approval Rating

81/100

Read more